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Ischemic acute renal failure: An inflammatory disease? Inflam-
mation plays a major role in the pathophysiology of acute renal
failure resulting from ischemia. In this review, we discuss the
contribution of endothelial and epithelial cells and leukocytes to
this inflammatory response. The roles of cytokines/chemokines
in the injury and recovery phase are reviewed. The ability of the
mouse kidney to be protected by prior exposure to ischemia or
urinary tract obstruction is discussed as a potential model to em-
ulate as we search for pharmacologic agents that will serve to
protect the kidney against injury. Understanding the inflamma-
tory response prevalent in ischemic kidney injury will facilitate
identification of molecular targets for therapeutic intervention.
Ischemic acute renal failure (ARF) is a syndrome that
develops following a sudden transient drop in total or re-
gional blood flow to the kidney [1–3]. Despite advances
in preventative strategies and support measures, this dis-
ease continues to be associated with significant morbid-
ity and mortality [4]. In this review, the pathogenesis
of ARF is discussed with an emphasis on the growing
body of evidence that ARF is an inflammatory disease.
The contributions of endothelial injury, leukocyte infiltra-
tion, and generation of inflammatory mediators by tubule
cells are emphasized. The response of the tubular ep-
ithelium to survive is also reviewed and is supplemented
with recent findings on the protective effects of ischemic
preconditioning.
THE INFLAMMATORY RESPONSE
Endothelial injury and leukocyte infiltration
In renal ischemia/reperfusion (I/R) injury, the inflam-
matory response results in endothelial activation and
injury, enhanced endothelial cell-leukocyte adhesion,
leukocyte entrapment, and a compromise in microvascu-
lar blood flow (Fig. 1) [5, 6]. These leukocyte-endothelial
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interactions impact the outer medulla to a greater extent
than the cortex, indicated by the marked vascular con-
gestion typically seen in this region of the kidney.
The concept that endothelial cells are a target of postis-
chemic injury was suggested as early as 1972 by Flores
et al [7] when they described endothelial swelling and nar-
rowing of the blood vessel lumen as important features
of postischemic injury. Recently, evidence for endothelial
dysfunction in the cortex has been described in studies
that demonstrated retrograde blood flow through per-
itubular capillaries upon reperfusion following ischemia
[8]. With reperfusion, a partial transient compromise
of the patency of the peritubular capillaries also was
noted. When human umbilical vein endothelial cells or
human embryonic kidneys cells expressing endothelial
nitric oxide synthase (NOS) were administered either in-
travenously or into the renal artery following ischemia,
cells implanted into the kidney, leading to partial func-
tional protection against injury [8]. In addition, following
prolonged ischemia (60 minutes) in the rat, peritubular
capillaries suffer permanent damage [9]. The number of
microvessels in the inner stripe of the outer medulla de-
clines and is associated with tubulointerstitial fibrosis and
altered concentrating ability.
In addition to endothelial cell damage, I/R up-regulates
adhesion molecules to promote endothelial-leukocyte
interactions. These adhesion molecules include inte-
grins, selectins, and members of the immunoglobulin su-
perfamily, including intercellular adhesion molecule-1
(ICAM-1), vascular cell adhesion molecule (VCAM),
and P-selectin. The role of ICAM-1 in renal injury was
demonstrated by experiments in which the administra-
tion of ICAM-1 antibody was found to be protective [10]
and the kidneys of ICAM-1 knockout mice were pro-
tected against ischemic injury [11]. Activation of endothe-
lial cells with up-regulation of adhesion molecules, as well
as injury to some cells leading to cell swelling and de-
creased vessel patency, will potentiate interactions with
leukocytes and platelets, possibly leading to mechanical
obstruction of small blood vessels [2].
There are several mechanisms by which leukocytes
potentiate renal injury. Leukocytes are activated by
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Fig. 1. Schematic illustration of the inflammatory mediators pro-
duced by tubular epithelial cells and activated leukocytes in renal is-
chemia/reperfusion (I/R) injury. Tubular epithelia produce TNF-a, IL-
1, IL-6, IL-8, TGF-b , MCP-1, ENA-78, RANTES, and fractalkines,
whereas leukocytes produce TNF-a, IL-1, IL-8, MCP-1, ROS, and
eicosanoids. The release of these chemokines and cytokines serve as
effectors for a positive feedback pathway enhancing inflammation and
cell injury.
inflammatory mediators, including cytokines, reactive
oxygen species (ROS), and eicosanoids, up-regulating
adhesion molecules to engage counter-receptors on
the activated endothelium. In addition, leukocytes are
recruited by chemokines, which are up-regulated by ROS
[12], and by the proinflammatory cytokines interleukin-1
(IL-1) and tumor necrosis factor-alpha (TNF-a) [13, 14].
Exposure of leukocytes to circulating cytokines also re-
duces their deformability and enhances their tendency
to be sequestered [15]. Sequestered leukocytes can then
potentiate injury by further generating more ROS and
eicosanoids, enhancing inflammation and vascular tone.
Activation of coagulation pathways, including comple-
ment, may also potentiate injury [16–18].
Leukocyte subgroups are likely to contribute in differ-
ent ways to I/R injury [5, 19, 20]. Myeloperoxidase ac-
tivity is elevated soon after the ischemic insult and may
originate from macrophages and/or neutrophils [21]. If
neutrophil accumulation is prevented, however, tissue in-
jury is ameliorated [10, 22]. It is possible that neutrophil
depletion models, however, may not adequately differ-
entiate involvement of neutrophils from T lymphocytes
and macrophages [21]. Later phases of ARF are char-
acterized by infiltration of macrophages and T lympho-
cytes which predominate over neutrophils [20, 23]. There
are also species differences with neutrophil accumulation
more readily apparent postischemia in the mouse than in
the rat [3]. Knockout mice lacking CD4+/CD8+, cell ad-
hesion receptors on T lymphocytes, are protected from
I/R injury [24], suggesting a causal role for T lympho-
cytes in mediating injury. In addition, blockade of T-cell
CD28-B7 costimulation protects against ischemic injury
in rats and significantly inhibits T-cell and macrophage in-
filtration and activation in situ [23]. It has been reported
that B7-1 plays a key role in leukocyte-endothelial in-
teractions along the ascending vasa recta that lead to
functional consequences after I/R. Anti-B7-1 antibodies
block adherence of CD28-expressing T cells to the B7-1
expressing endothelial cells of these postcapillary venules
and this is associated with much less postischemic vascu-
lar congestion [25].
The role of the T cell, however, has been recently ques-
tioned. Mice deficient in recombination-activating gene
(RAG)-1 lack T and B cells and do not produce im-
munoglobulins or T-cell receptor proteins. In the absence
of these cells and their receptors, RAG-1–deficient mice
are not protected from ARF induced by ischemia. Tubu-
lar necrosis and neutrophil infiltration are present to a
comparable degree, as in wild-type mice [26]. These mice
have, however, an increased population of natural killer
T cells which express CD28. Hence, it is possible that the
CD28/B7-1 interaction at the level of the vasa recta can
still occur and may explain the lack of a functional differ-
ence between the RAG-1–deficient and wild-type mice
[27, 28].
Generation of inflammatory mediators by tubule cells
In addition to the contribution of leukocytes and en-
dothelial cells to the inflammatory response following
ischemic injury, the renal tubular epithelium also gener-
ates mediators that potentiate inflammation (Fig. 1) [29].
These include proinflammatory cytokines such as TNF-a,
IL-6, IL-1b , and transforming growth factor-b (TGF-
b). Chemotactic cytokines, also known as chemokines,
are also produced. These include monocyte chemoat-
tractant protein-1 (MCP-1), IL-8, regulated upon activa-
tion, normal T-cell expressed and secreted (RANTES),
and epithelial neutrophil-activating protein 78 (ENA-78)
[30–32]. MCP-1 and IL-8 are produced by mouse corti-
cal proximal tubular cells following adenosine triphos-
phate (ATP) depletion in vitro [33]. Bone morphogenetic
protein-7 (BMP-7), a member of the TGF-b superfamily,
has been reported to protect against ischemic injury by
acting on proximal tubular epithelia to reduce basal and
TNF-a stimulated expression of MCP-1 and IL-8 [34];
BMP-7 also reduces levels of the proinflammatory cy-
tokines IL-6 and IL-1b [34]. The reduction in macrophage
infiltration that follows may explain its protective effect.
Fractalkines are also produced by renal epithelial cells
[35]. Fractalkines are members of the chemokine super-
family that are directly tethered to the plasma membrane
via a long mucin stalk. They have a combined function of a
chemokine and an adhesion molecule. On kidney epithe-
lial cells, fractalkines induce migration and adhesion of
leukocytes, facilitating monocyte-induced cell injury [35].
a-Melanocyte-stimulating hormone (MSH), an endoge-
nous anti-inflammatory cytokine, protects against injury
associated with ischemic ARF [36]. MSH acts directly on
renal tubules where it binds to melanocortin receptor to
482 Forefronts in Nephrology
inhibit activation of genes that cause inflammatory and
cytotoxic renal injury [36].
Proximal tubular epithelia may also modulate T lym-
phocyte activity [33, 37]. CD40 is expressed by epithe-
lial cells of the proximal tubule and serves as a recep-
tor for CD154, its ligand typically present on T cells.
When human proximal tubular epithelia are exposed to
CD154, ligation of CD40, in turn, engages TNF receptor-
activating factor 6 (TRAF6). CD40 and TRAF6 then
translocate from separate membrane microdomains to
associate with one another in the cytoplasmic compart-
ment, where TRAF6 in turn activates phosphorylation of
the jun-kinase (JNK) and p38 mitogen-activated protein
kinase (MAPK) pathways, which, in turn, stimulate IL-
8 and MCP-1 production by these cells [33]. CD40 also
induces RANTES production by human renal tubular ep-
ithelia, an effect which is amplified by production of IL-4
and IL-13 by Th2 cells, a subpopulation of T cells [37].
PROXIMAL TUBULE CELL INJURY
In most animal models of ARF, it is the S3 segment
of the proximal tubule in the outer stripe of the outer
medulla and not the medullary thick ascending limb
(MTAL) that is most susceptible to ischemic injury [38–
40]. This is likely due to ischemia-related reductions in mi-
crovascular blood flow and oxygen delivery to the outer
medulla at a time when cortical blood flow is returned
to near normal levels. In addition, unlike the MTAL, S3
segments have a limited capacity to undergo anaerobic
metabolism (i.e., glycolysis). Although compared to the
proximal tubule, there are fewer histologic changes in the
MTAL, ischemia modifies the expression of a large num-
ber of genes, and a number of cytokines are produced and
secreted by this segment [41, 42]. These cytokines, in ad-
dition to those produced by the S3 segment, likely impact
the microvasculature, serving as effectors for a positive
feedback pathway enhancing inflammation and vascular
obstruction.
Sublethal injury
Sublethal injury of the proximal tubular epithelium as
a result of ATP depletion leads to early changes in the
actin cytoskeleton, loss of junctional complexes, includ-
ing tight junctions and adherens junctions, as well as a
change in localization of cell adhesion molecules and po-
larized membrane proteins (Fig. 2) [4, 43–45]. Following
I/R, intracellular calcium increases and calpain, a pro-
tease, and NOS are activated. Severing of actin filaments
and digestion of actin binding proteins follow, which, in
turn, disrupt the cortical actin cytoskeleton [43, 46].
In proximal tubular epithelia, tight junctions at api-
colateral borders are disrupted, either in response to
loss of the cortical actin cytoskeleton or in response
to inflammatory mediators. The tight junction proteins,
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Fig. 2. Schematic illustration of the cycle of tubular epithelial cell in-
jury and repair following renal ischemia/reperfusion. Tubular epithe-
lia are typically cuboidal in shape and apically-basally polarized; the
Na+/K+-ATPase localizes to basolateral plasma membranes, whereas
cell adhesion molecules, such as integrins localize basally. In response
to ischemia reperfusion, the Na+/K+-ATPase appears apically, and in-
tegrins are detected on lateral and basal plasma membranes [62]. Some
of the injured epithelial cells undergo necrosis and/or apoptosis detach-
ing from the underlying basement membrane into the tubular space
where they contribute to tubular occlusion. Viable cells that remain at-
tached, dedifferentiate, spread, and migrate to repopulate the denuded
basement membrane. With cell proliferation, cell-cell and cell-matrix
contacts are restored, and the epithelium redifferentiates and repolar-
izes, forming a functional, normal epithelium.
ZO-1, ZO-2, and cingulin, are dephosphorylated, form-
ing large insoluble complexes that associate with cy-
toskeletal elements, including fodrin [47]. Reassembly
of tight junctions, in turn, depends on tyrosine kinase
activity. Loss of tight junction integrity alters both para-
cellular permeability and cell polarity with the increase
in permeability promoting back-leak of glomerular fil-
trate. Na+/K+-ATPase, which localizes normally to the
basolateral plasma membrane, appears after ischemia
on the apical plasma membrane [46], thereby reducing
the efficiency of transcellular sodium transport and in-
creasing intraluminal sodium delivery to the distal tubule.
The enhanced distal sodium delivery may activate tubu-
loglomerular feedback at the macula densa, resulting in
vasoconstriction of preglomerular arterioles and a de-
cline in glomerular filtration rate (GFR) [48]. The mis-
localized Na+/K+-ATPase may also explain the marked
increase in fractional sodium excretion [49] in patients
with ischemic ARF as well as the increase in fractional
sodium and lithium excretion, normally cotransported by
the proximal and distal tubules, in transplant recipients
during postischemic injury to the renal allograft [50].
ATP depletion also disrupts the adherens junction
which contains transmembrane cadherin proteins that
link to the actin cytoskeleton and signaling proteins via
catenins [44]. In mouse proximal tubular cells following
ATP depletion both b-catenin and plakoglobin are tyro-
sine phosphorylated [51], possibly through activation of
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the tyrosine kinase c-Src [52]; E-cadherin, a-catenin and
b-catenin are withdrawn from the plasma membrane as
intact cadherin-catenin complexes [53]. With longer du-
rations of ATP depletion in vitro and ischemia of kidney
in vivo, E-cadherin is degraded and complexes are par-
tially disrupted [54].
Dissociation of the zonula adherens in response to
ATP depletion also induces nuclear translocation of
b-catenin and T-cell factor (TCF)/lymphoid enhancer
factor-1 (LEF-1), a transcriptional factor with which
b-catenin associates [53]. The translocation of the b-
catenin-TCF/LEF-1 complex into the nucleus suggests
that ATP depletion may activate the wnt/wingless sig-
nal transduction pathway, known to modulate the
expression of genes that regulate cell proliferation, apop-
tosis, and differentiation [55]. The expression of these
genes in mammalian cells encode c-myc, cyclin, and
E-cadherin, which likely function in those cell responses
necessary for regeneration and repair of the kidney ep-
ithelium. It remains unclear, however, whether inflam-
matory mediators activate wnt/wingless signaling through
b-catenin. The inflammatory cytokines, TNF-a, IL-1,
and interferon-c (IFN-c), produce a number of injuri-
ous changes in proximal tubular epithelial cells [56]. The
actin cytoskeleton is disrupted and E-cadherin is dis-
persed, suggesting affects on b-catenin signaling via the
wnt/wingless pathway.
Inflammatory mediators have also been implicated in
mediating exfoliation of epithelial cells [56, 57] and thus
may add to their role in the pathogenesis of tubular in-
jury. The pro-inflammatory cytokines, TNF-a, IL-1, and
IFN-c, disrupt cell-matrix adhesion dependent on b 1 in-
tegrin, inducing cell shedding into the lumen. Integrins
anchor epithelial cells to extracellular matrix proteins in
the basement membrane which in the proximal tubule
include laminin-1, -10, and collagen IV [58]. In the kid-
ney, b 1 integrins are the major receptor family expressed
along the nephron. In proximal tubular epithelia, the a6
and a2 integrin subunits partner with b 1, forming recep-
tors for laminin and collagen expressed on basal plasma
membranes. Following ATP depletion in vitro, the a3 [59]
and b 1 integrin subunits [60] redistribute to apical plasma
membranes, suggesting that the loss of cell-matrix adhe-
sion facilitates cell exfoliation into the luminal space [59].
In this location, continued cell-cell interactions via inte-
grin may contribute to occlusion. Furthermore, the ap-
pearance of apical integrin on the surviving epithelium
may potentiate occlusion by facilitating cell-cell interac-
tions with the obstructive cast [59, 61]. However, in the
postischemic kidney in vivo, the b 1 integrin subunit is not
detected by immunohistochemistry on apical surfaces of
the surviving epithelium or on exfoliated cells in the ob-
structive cast [62, 63], possibly due to endocytosis and sub-
sequent degradation. What remains unclear is whether
other integrin families expressed in the kidney in vivo or
induced by ischemic injury, are present in these locations.
The presence of other integrin families, particularly those
that recognize the arginine, glycine, aspartic (RGD) se-
quence, may explain the ability of soluble RGD peptides
[64] to interfere with cell-cell and cell-fibronectin inter-
actions [62] in the obstructive cast, ameliorating ischemic
injury and decreasing intratubular obstruction.
The proximal tubular epithelium can also undergo
apoptosis or necrosis depending on the severity of injury.
This topic is covered in detail by Kaushal et al [65] and
Dagher [66].
Protection against injury by ischemic preconditioning
An area of increasing interest is the possibility of ren-
dering an organ resistant to subsequent injury by a prior
insult or preconditioning maneuver. Ischemic precondi-
tioning of the kidney confers protection against a subse-
quent ischemic attack [67]. Several candidates that could
potentially serve as mediators of preconditioning have
been identified (reviewed in [3]). Of these, the NOS path-
way is particularly important to mention. Recently, this
laboratory demonstrated that inducible NOS (iNOS) is
responsible for a component of the long-term protection
afforded the kidney by ischemic preconditioning [68].
Thirty minutes of prior ischemia results in a prolonged
increase in the expression of iNOS and endothelial NOS
(eNOS) as well as heat shock protein 25 (HSP25). In ad-
dition, there is increased interstitial expression of alpha-
smooth muscle actin (a-SMA), an indicator of long-term
renal interstitial changes. Gene deletion of iNOS, but
not eNOS, increased kidney susceptibility to ischemia, as
did treatment with pharmacologic inhibitors of nitric ox-
ide synthesis, including N-nitro-L-arginine (L-NNA) and
L-N6-(1-iminoethyl) lysine (L-NIL), the latter a specific
inhibitor of iNOS. When the initial period of ischemia
was reduced (15 minutes), there was less protection of the
kidney from subsequent ischemia on day 8. Under these
conditions, there was no sustained increase in iNOS or
eNOS expression, and protection was not abolished by
L-NIL treatment, suggesting that the residual protection
was not related to iNOS. In addition, renal function was
not impaired and expression of interstitial a-SMA did not
change. The data indicate that iNOS plays an important
role in kidney protection afforded by ischemic precondi-
tioning, resulting in longer periods of ischemia, and that
persistent long-term changes in the renal interstitium may
be critical in affording this protection by sustaining iNOS
synthesis. In addition, this study is the first to demonstrate
in any organ system that partial protection persists up to
12 weeks after an initial ischemic event.
MAPKs are also likely to be involved in affording
protection following ischemic preconditioning [67, 69].
MAPKs are ubiquitously expressed serine/threonine ki-
nases which in mammalian cells play central roles in
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determining if the response to multiple signaling inputs
is proliferation, differentiation, or apoptosis. In mam-
malian cells, three MAPK cascades have been identi-
fied. The first, the extracellular-regulated protein kinase
(ERK) pathway, is activated by growth factors and many
other agonists, including vasoactive peptides; ERKs are
involved in cell proliferation and differentiation. JNK,
also known as stress-activated protein kinase (SAPK),
and p38 are components of two other MAPK cascades.
JNK and p38 are activated by inflammatory cytokines
(TNF and IL-1) and by cell stress [70]. When the kid-
ney is preconditioned to injury by ischemia, ischemia-
induced activation of JNK and p38 is markedly reduced,
as is activation of their upstream MAPK kinases (MKK7,
MKK4, and MKK3/6). By contrast, activation of ERK1/2
and its upstream MAPK kinase activator, MKK3/4, is un-
altered [67]. Thus, the relative ratio of ERK1/2 activation
to JNK or p38 activation is enhanced in the precondi-
tioned postischemic kidney. This suggests that activation
patterns of MAPKs may explain the endogenous ability
of the kidney to protect itself against injury.
CONCLUSION
Inflammation is a significant component of renal I/R
injury, playing a considerable role in its pathophysiology.
Although significant progress has been made in defin-
ing the major components of this process, the complex
cross-talk between endothelial cells, inflammatory cells,
and the injured epithelium with each generating and of-
ten responding to cytokines and chemokines is not well
understood. In addition, we have not yet taken full advan-
tage of the large body of data on inflammation in other
organ systems. Furthermore, preconditioning the kidney
to afford protection to subsequent bouts of ischemia may
serve as a useful model challenging us to therapeutically
mimic endogenous mechanisms of protection. A better
understanding of the pathophysiology underlying ARF
with better ways to limit the inflammatory component
will allow promising therapies to be identified.
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